Metabolic Reprogramming in Kidney Cancer: Implications for Therapy
Elena Tena Edo
Kidney cancer, particularly clear cell renal cell carcinoma (ccRCC), has emerged as a paradigm for cancer metabolic reprogramming, exhibiting distinctive alterations that drive tumor progression and therapeutic resistance. This comprehensive review synthesizes current knowledge of the molecular mechanisms underlying metabolic dysregulation in kidney cancer, with emphasis on the central role of VHL...
REVIEW | Published: 07 Aug 2025
Annals of Urologic Oncology, Articles, Online First